CERTOLIZUMAB PEGOL for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 8,179 adverse event reports in the FDA FAERS database where CERTOLIZUMAB PEGOL was used for Psoriasis.
Most Reported Side Effects for CERTOLIZUMAB PEGOL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 23,838 | 24.1% | 1,165 | 3,601 |
| Rheumatoid arthritis | 17,782 | 17.9% | 1,735 | 3,510 |
| Pain | 13,929 | 14.1% | 1,494 | 2,958 |
| Fatigue | 11,438 | 11.5% | 1,764 | 3,013 |
| Off label use | 10,281 | 10.4% | 1,629 | 3,112 |
| Rash | 9,663 | 9.8% | 1,679 | 2,832 |
| Alopecia | 9,111 | 9.2% | 1,589 | 2,504 |
| Maternal exposure during pregnancy | 9,013 | 9.1% | 1,288 | 2,039 |
| Arthralgia | 8,993 | 9.1% | 1,591 | 2,928 |
| Abdominal discomfort | 8,615 | 8.7% | 1,581 | 2,564 |
| Joint swelling | 8,607 | 8.7% | 1,690 | 2,643 |
| Systemic lupus erythematosus | 8,212 | 8.3% | 1,760 | 2,351 |
| Pemphigus | 7,869 | 7.9% | 1,564 | 2,114 |
| Contraindicated product administered | 7,783 | 7.9% | 1,059 | 2,122 |
| Swelling | 7,748 | 7.8% | 1,641 | 2,419 |
Other Indications for CERTOLIZUMAB PEGOL
Rheumatoid arthritis (47,602)
Product used for unknown indication (19,011)
Psoriatic arthropathy (10,537)
Crohn's disease (8,758)
Ankylosing spondylitis (7,776)
Off label use (2,256)
Axial spondyloarthritis (1,313)
Colitis ulcerative (432)
Juvenile idiopathic arthritis (385)
Spondyloarthropathy (309)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
METHOTREXATE (6,628)
HUMIRA (6,346)